Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions.

Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions.

Item

http://www.wikidata.org/entity/Q37838534

Q37838534

about

Systemic Treatment of Pediatric Psoriasis: A Review Managing Patients With Psoriasis in the Busy Clinic: Practical Tips for Health Care Practitioners New and emerging biologic therapies for moderate-to-severe plaque psoriasis: mechanistic rationales and recent clinical data for IL-17 and IL-23 inhibitors Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis Topical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea Treatments Nanoparticle-Enabled Transdermal Drug Delivery Systems for Enhanced Dose Control and Tissue Targeting A patient-centred approach to biological treatment decision making for psoriasis: an expert consensus Under-Treatment of Patients with Moderate to Severe Psoriasis in the United States: Analysis of Medication Usage with Health Plan Data Diagnosis and management of psoriasis.Diagnostic et prise en charge du psoriasis The Challenge of Managing Psoriasis: Unmet Medical Needs and Stakeholder Perspectives.Economic impact of biologic utilization patterns in patients with psoriatic arthritis Management of psoriasis in adolescence.Recommendations for a patient-centered approach to the assessment and treatment of scalp psoriasis: a consensus statement from the Asia Scalp Psoriasis Study Group.Apremilast.Adjuvant Narrow Band UVB Improves the Efficacy of Oral Azithromycin for the Treatment of Moderate to Severe Inflammatory Facial Acne Vulgaris.Comparative effectiveness of less commonly used systemic monotherapies and common combination therapies for moderate to severe psoriasis in the clinical setting Qualifying unmet needs and improving standards of care in psoriatic arthritis.Patient satisfaction with treatments for moderate-to-severe plaque psoriasis in clinical practice Distribution pattern of psoriasis, anxiety and depression as possible causes of sexual dysfunction in patients with moderate to severe psoriasis.Apremilast (Otezla): A New Oral Treatment for Adults With Psoriasis and Psoriatic Arthritis.Treatment patterns and costs for anti-TNFα biologic therapy in patients with psoriatic arthritis.A multicenter, randomized, open-label pilot trial assessing the efficacy and safety of etanercept 50 mg twice weekly followed by etanercept 25 mg twice weekly, the combination of etanercept 25 mg twice weekly and acitretin, and acitretin alone in pa Treatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a Phase 2b randomized clinical trial.Worldwide utilization of topical remedies in treatment of psoriasis: a systematic review.PLA2R antibodies and PLA2R glomerular deposits in psoriasis patients with membranous nephropathy.The adverse effects of the methoxsalen and ultraviolent A radiation on spermatogenesis in mice Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice setting.A randomized, double-blind, placebo-controlled study to evaluate the addition of methotrexate to etanercept in patients with moderate to severe plaque psoriasis.Evolocumab lowers LDL-C safely and effectively when self-administered in the at-home setting Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3)The skin tissue is adversely affected by TNF-alpha blockers in patients with chronic inflammatory arthritis: a 5-year prospective analysis.Treatment patterns with etanercept and adalimumab for psoriatic diseases in a real-world setting An evolution in switching therapy for psoriasis patients who fail to meet treatment goals.Tolerability of Crisaborole Ointment for Application on Sensitive Skin Areas: A Randomized, Double-Blind, Vehicle-Controlled Study in Healthy Volunteers.A case series of the effects of a novel composition of a traditional natural preparation for the treatment of psoriasis.Efficacy of Secukinumab for Moderate-to-Severe Head and Neck Psoriasis Over 52 Weeks: Pooled Analysis of Four Phase 3 Studies.Long-Term Cost-Effectiveness Analysis of Etanercept and Adalimumab for Plaque Psoriasis not Associated with Arthritis.Treatment sequencing after failure of the first biologic in cost-effectiveness models of psoriasis: a systematic review of published models and clinical practice guidelines.Evaluation of psoriasis patients' attitudes toward benefit-risk and therapeutic trade-offs in their choice of treatments.

P2860

Q26753026-AA802DA9-A4FE-4922-922F-882A7A7B5888 Q26771785-7235D257-4E14-4304-ADA6-DA5DBB8403B7 Q26800937-A627D0F7-1EB1-4FEA-886C-3437ED3318CA Q27693878-B8AB8C41-F08E-4189-BBBB-9D802F6CB69B Q28072685-F0C0273D-D704-420E-8008-B34CE107D48B Q28079462-4603083B-9D0A-4042-8495-1516CD7D0DEC Q28082166-247025DD-FEBA-43F7-801C-09079387BF4D Q31146263-5CC83D6D-91AA-466E-AC22-B010B09A9F6C Q33558495-AC0BFAD9-16AD-419A-B9DE-B9F53CAA20E1 Q33558550-255B1037-7349-43F1-9A82-498540305A46 Q33572834-0763FCF4-237C-4789-AC43-DB2740928DFA Q33840422-FBF5F5E9-B92B-49A5-927C-633362F005F1 Q34415058-70EC2E80-58F3-4D05-8CB0-93D83DD26458 Q34452903-FD26C811-C765-4852-8349-22485868B737 Q34612877-2134153D-D5FF-42BD-8108-8C149FDD1087 Q34738374-F4EECC87-D5D7-4B24-A52C-93FFA0609C63 Q34743112-517BF952-5305-402D-A13F-BB7370D15B83 Q34803582-96A02AE0-B402-4C80-A0D5-707DC50A5211 Q34997467-1087CC5C-E72C-4B15-8E3E-7CAB435EB47E Q35892185-B4383B67-D601-4D21-A5CF-A98706B6E321 Q35896444-7AE1B60C-860C-4F66-8807-FD2A8CD44E13 Q36052215-C24400AA-EAF9-477C-B5E6-A70F5A187132 Q36085078-D3DBD6A1-4ED8-4542-9730-5FAB03C1E95D Q36157003-0F2D4956-BC56-411B-AFBD-20A478843D6E Q36175745-65E96BD2-EDD5-47B0-BB1F-AC51E05C8164 Q36201382-3CD8EFD8-14E8-4E64-B8F4-D517BC5DC081 Q36259977-108C560A-0B53-4D5F-A5AD-F8DA11DD20C5 Q36334747-2E79B5CB-0191-4327-A563-946771AF37C0 Q36417100-03249BD7-F4B1-427E-9461-3AB66ACFD3D8 Q36665368-D9FA8336-2E25-44D9-8356-CD249C60D2FC Q36968787-FA773E1C-CF4B-4BD2-987D-985995E1B4D6 Q37196596-3BCC5C01-BE56-4377-9157-E87F635128A6 Q37221862-240735C4-5486-43D4-A289-0E20AAB7BDC1 Q37295966-069446D3-9865-4E4F-B613-C4A01E714BF0 Q37302054-FC7BAA3D-16A6-4BD1-B8E5-E7454C32E6F2 Q37346037-45FC4E49-6A10-440C-A9F4-37A5A2B4DDEB Q37432244-E03A93FE-2D23-4A8F-980D-1A8291D5AFDA Q37468351-034FB74F-2E37-49C2-873F-E59C590EE451 Q37660470-E98AA0E8-179D-4176-972D-9AA541621674 Q37682855-A633C240-B712-4240-8AD4-9A8CE5E42D1A

P2860

Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions.

Item

http://www.wikidata.org/entity/Q37838534

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 08 February 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs